Literatur
Ginzburg Y, Rivella S (2011) β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism. Blood 118:4321–4330
Schanz J, Steidl C, Fonatsch C et al (2011) Coalesced multicentric analysis of 2,351 patients with myelodysplastic syndromes indicates an underestimation of poor-risk cytogenetics of myelodysplastic syndromes in the international prognostic scoring system. J Clin Oncol 29:1963–1970
http://www.dgho-onkopedia.de/onkopedia/leitlinien/mds
Rose C, Brechignac S, Vassilief D et al (2010) Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM (Groupe Francophone des Myélodysplasies). Leuk Res 34:864–870
Porter J, Galanello R, Saglio G et al (2008) Relative response of patients with myelodysplastic syndromes and other transfusion-dependent anaemias to deferasirox (ICL670): a 1-yr prospective study. Eur J Haematol 80:168–176
Interessenkonflikt
Der korrespondierende Autor gibt für sich und seinen Koautor an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moosmann, N., Braess, J. 78-jähriger Patient mit Hyperferritinämie bei vermuteter Hämochromatose und milder Anämie. Internist 53, 771–774 (2012). https://doi.org/10.1007/s00108-012-3079-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00108-012-3079-5